Ani Pharmaceuticals (ANIP) Equity Average (2021 - 2023)
Ani Pharmaceuticals (ANIP) posted Equity Average of $339.0 million for Q1 2023, little changed sequentially from $337.6 million in Q4 2022, and down 3.8% YoY from $352.4 million in Q1 2022.
Ani Pharmaceuticals (ANIP) Equity Average (2021 - 2023) Analysis & Trends
Ani Pharmaceuticals has reported Equity Average for 3 years, with the latest figure at $339.0 million in Q1 2023.
- Quarterly Equity Average fell 3.8% year-over-year to $339.0 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $339.0 million (down 3.8% YoY) and the FY2022 annual result came in at $348.6 million, up 25.76% from the prior year.
- Equity Average was little changed at $339.0 million in Q1 2023 per ANIP's latest filing, from $337.6 million in the prior quarter.
- Over five years, Equity Average peaked at $352.4 million in Q1 2022 and troughed at $191.7 million in Q3 2021.
- A 3-year average of $310.6 million and a median of $337.6 million in 2022 frame the typical range for Equity Average.
- The sharpest annual moves came in 2022 and 2023: Equity Average surged 75.74% in 2022, then slipped 3.8% in 2023.
- Over 3 years, Equity Average stood at $275.1 million in 2021, then gained by 22.73% to $337.6 million in 2022, then climbed by 0.42% to $339.0 million in 2023.
- According to Business Quant data, Equity Average over the past three periods registered $339.0 million, $337.6 million, and $336.8 million for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Average (Quarter) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 339.01 Mn |
| Dec 31, 2022 | 337.61 Mn |
| Sep 30, 2022 | 336.82 Mn |
| Jun 30, 2022 | 341.53 Mn |
| Mar 31, 2022 | 352.42 Mn |
| Dec 31, 2021 | 275.07 Mn |
| Sep 30, 2021 | 191.66 Mn |